Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118546096A reveals a novel Pd-catalyzed route for chiral tetrahydropyridazines, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel 7-step synthesis for rosuvastatin calcium intermediates. High yield, mild conditions, cost-effective manufacturing for global supply chains.
Novel amide intermediate process for HMG-CoA inhibitors. Mild conditions, high purity, scalable manufacturing for global pharma supply chains.
Discover a novel Ezetimibe synthesis method using titanium Lewis acids. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable routes.
Novel 7-step route for Rosuvastatin calcium intermediate using vinyl chloride. Cost-effective, scalable, high purity manufacturing solution.
Patent CN110804062B details a high-yield synthesis of chiral lactone for biotin. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN116731070B reveals mild asymmetric synthesis for chiral ligands. Offers supply chain stability and cost reduction for pharma intermediates.
Patent CN109503681B reveals a novel asymmetric synthesis for 2-Fluoro-L-ristosamine. Discover cost-effective manufacturing and reliable supply chain solutions for this critical pharmaceutical intermediate.
Patent CN102517353A details a green enzymatic route for heterocyclic ketones. Offers high ee values and mild conditions for pharma intermediates.
Discover advanced synthesis routes for chiral imidazolidinone derivatives targeting M1 receptors. Enhance safety profiles and reduce manufacturing costs with our scalable processes.
Patent CN104592163A enables cost-effective chiral pyrrolidine synthesis. Enhances supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102212081B details a novel asymmetric synthesis for statin side chains, offering high purity and eliminating resolution steps for cost-effective manufacturing.
Patent CN1100410A details a novel route for (+)-2-(3,4-dichlorophenyl)-4-hydroxybutylamine using N-methylglucamine resolution and borane reduction for high-purity tachykinin antagonists.
Patent CN107573285B enables high-purity quinolinone synthesis via Pd-catalyzed decarboxylative cycloaddition, offering cost reduction and scalable supply chain solutions.
Novel intermediates and methods for CPT-11 and mappicine synthesis offering improved yield and chiral control for pharmaceutical manufacturing supply chains.
Novel patent CN115160158B details a reducing-agent-free route for high-purity chiral tertiary leucinol, offering significant supply chain stability and cost optimization for pharmaceutical manufacturing.
Novel patent CN105085322A offers high selectivity synthesis for AHU-377 intermediate ensuring supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN101845025A reveals a mild, high-yield route for 3-acyl-oxazolidinones, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN1331883C reveals an efficient synthesis of perindopril intermediates using natural amino acids, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Patent CN118290435A reveals cost-effective glabridin synthesis. Enhances supply chain reliability and purity for cosmetic and pharma applications.